Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Am J Kidney Dis. 2014 Oct 14;65(3):394–402. doi: 10.1053/j.ajkd.2014.07.026

Figure 3.

Figure 3

Median (25th percentile – 75th percentile) times to end-stage renal disease, by patient characteristic, from five starting points: eGFR 30 ml/min/1.73 m2, eGFR 15 ml/min/1.73 m2, and 5%, 10%, and 20% 1-year risk of end-stage renal disease†

†Times to end-stage renal disease estimated accounting for the competing risk of death and adjusting to eGFR 30 or 15 ml/min/1.73 m2 in analyses from eGFR thresholds and 5%, 10%, and 20% 1-year end-stage renal disease (ESRD) risk in analyses from ESRD risk thresholds. Dashed lines represent an imputed interquartile range and are truncated at the last observed follow-up time.